Is trintellix a controlled substance?

Question

Accepted Answer

Short answer: No. Trintellix (generic name vortioxetine) is not a controlled‑substance under U.S. federal law (it is not listed in the DEA’s Schedules I–V).

What that means

	U.S. federal schedule	What it implies for Trintellix
Schedule I–V	Drugs that are regulated for prescribing because of potential for abuse or dependence (e.g., heroin, oxycodone, methadone).	Trintellix is not in any of these schedules.
Prescription medication	Vortioxetine is available only with a prescription from a licensed clinician.	It requires a doctor's order, but the prescription is not considered “controlled‑drug” paperwork.
State regulations	Some states have additional rules for certain medications.	Vortioxetine is still treated as a standard prescription drug; no special “controlled‑drug” designation at the state level.
International	In many other countries, including Canada and most European nations, Trintellix is also not classified as a controlled substance.	It is generally available only by prescription, not as a schedule‑I or schedule‑II drug.

Why it isn’t controlled

Pharmacology – Vortioxetine is a selective serotonin reuptake inhibitor (SSRI) with additional activity at serotonin receptors. It does not have the pharmacologic properties that typically lead to abuse potential (e.g., euphoria, respiratory depression, etc.).
Safety profile – Clinical trials and post‑marketing data have not shown a pattern of dependence or misuse that would warrant scheduling. The drug is considered relatively safe and well‑tolerated, with side‑effects mainly involving nausea, constipation, and mild dizziness.
Regulatory history – When the FDA approved vortioxetine in 2013, it was cleared as a non‑controlled prescription medication. Since then, no changes have been made to its scheduling status.

Practical implications for patients and providers

Prescription workflow: Because it isn’t a controlled drug, the prescribing process does not involve the additional paperwork (e.g., DEA Form 10‑G in the U.S.) that is required for Schedule II–IV drugs.
Refills: Trintellix can be refilled under normal prescription rules. In the U.S., most states allow up to 90 days’ supply for a new prescription, but the exact limits can vary.
Insurance coverage: Most insurance plans treat it like a standard prescription drug. Because it’s not controlled, it typically isn’t subject to the stricter copayment or prior‑authorization requirements that some controlled‑substance prescriptions face.

Bottom line

Trintellix/vortioxetine is a prescription medication, not a controlled substance. It’s regulated in the same way as most other antidepressants, requiring a doctor’s prescription and a standard pharmacy refill process, but it does not carry the additional restrictions that come with Schedule I–V drugs. If you have any concerns about how it’s prescribed or dispensed in your specific jurisdiction, it’s a good idea to talk directly with your prescriber or pharmacist.

Ask Questions, Get Industry Insights … Instantly

Recent Questions

Is trintellix a controlled substance?

What that means

Why it isn’t controlled

Practical implications for patients and providers

Bottom line